995 related articles for article (PubMed ID: 28459043)
1.
Yadav MK; Chae SW; Go YY; Im GJ; Song JJ
Front Cell Infect Microbiol; 2017; 7():125. PubMed ID: 28459043
[No Abstract] [Full Text] [Related]
2. Mucosal biofilm formation on middle-ear mucosa in a nonhuman primate model of chronic suppurative otitis media.
Dohar JE; Hebda PA; Veeh R; Awad M; Costerton JW; Hayes J; Ehrlich GD
Laryngoscope; 2005 Aug; 115(8):1469-72. PubMed ID: 16094127
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory activity of N-acetylcysteine on tympanostomy tube biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Jun Y; Youn CK; Jo ER; Cho SI
Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109622. PubMed ID: 31404783
[TBL] [Abstract][Full Text] [Related]
4. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections.
Hou W; Sun X; Wang Z; Zhang Y
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5624-31. PubMed ID: 22736609
[TBL] [Abstract][Full Text] [Related]
5.
Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
[No Abstract] [Full Text] [Related]
6. Eugenol: a phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms.
Yadav MK; Chae SW; Im GJ; Chung JW; Song JJ
PLoS One; 2015; 10(3):e0119564. PubMed ID: 25781975
[TBL] [Abstract][Full Text] [Related]
7. Global transcriptome responses including small RNAs during mixed-species interactions with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Miller CL; Van Laar TA; Chen T; Karna SLR; Chen P; You T; Leung KP
Microbiologyopen; 2017 Jun; 6(3):. PubMed ID: 27868360
[TBL] [Abstract][Full Text] [Related]
8. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media.
Hall-Stoodley L; Hu FZ; Gieseke A; Nistico L; Nguyen D; Hayes J; Forbes M; Greenberg DP; Dice B; Burrows A; Wackym PA; Stoodley P; Post JC; Ehrlich GD; Kerschner JE
JAMA; 2006 Jul; 296(2):202-11. PubMed ID: 16835426
[TBL] [Abstract][Full Text] [Related]
9. Virulence of methicillin-resistant Staphylococcus aureus modulated by the YycFG two-component pathway in a rat model of osteomyelitis.
Wu S; Liu Y; Lei L; Zhang H
J Orthop Surg Res; 2019 Dec; 14(1):433. PubMed ID: 31831035
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics Enhance Prevention and Eradication Efficacy of Cathodic-Voltage-Controlled Electrical Stimulation against Titanium-Associated Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms.
Canty MK; Hansen LA; Tobias M; Spencer S; Henry T; Luke-Marshall NR; Campagnari AA; Ehrensberger MT
mSphere; 2019 May; 4(3):. PubMed ID: 31043516
[TBL] [Abstract][Full Text] [Related]
11. Change in Detection Rate of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa and Their Antibiotic Sensitivities in Patients with Chronic Suppurative Otitis Media.
Kim SH; Kim MG; Kim SS; Cha SH; Yeo SG
J Int Adv Otol; 2015 Aug; 11(2):151-6. PubMed ID: 26381007
[TBL] [Abstract][Full Text] [Related]
12. Interaction between Staphylococcus aureus and Pseudomonas aeruginosa is beneficial for colonisation and pathogenicity in a mixed biofilm.
Alves PM; Al-Badi E; Withycombe C; Jones PM; Purdy KJ; Maddocks SE
Pathog Dis; 2018 Feb; 76(1):. PubMed ID: 29342260
[TBL] [Abstract][Full Text] [Related]
13. A mucosal model to study microbial biofilm development and anti-biofilm therapeutics.
Anderson MJ; Parks PJ; Peterson ML
J Microbiol Methods; 2013 Feb; 92(2):201-8. PubMed ID: 23246911
[TBL] [Abstract][Full Text] [Related]
14. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media.
Ehrlich GD; Veeh R; Wang X; Costerton JW; Hayes JD; Hu FZ; Daigle BJ; Ehrlich MD; Post JC
JAMA; 2002 Apr; 287(13):1710-5. PubMed ID: 11926896
[TBL] [Abstract][Full Text] [Related]
15. [Formation characteristics and significance of bacteria biofilm in middle ear mucosa of rats with chronic suppurative otitis].
Hou W; Li X; Xiao H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jan; 26(1):30-3. PubMed ID: 22509693
[TBL] [Abstract][Full Text] [Related]
16. Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines-implications for delayed wound closure?
Trøstrup H; Lerche CJ; Christophersen LJ; Thomsen K; Jensen PØ; Hougen HP; Høiby N; Moser C
Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28645160
[TBL] [Abstract][Full Text] [Related]
17. Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa.
Price CE; Brown DG; Limoli DH; Phelan VV; O'Toole GA
J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31792010
[TBL] [Abstract][Full Text] [Related]
18. The role of bacterial biofilms in chronic infections.
Bjarnsholt T
APMIS Suppl; 2013 May; (136):1-51. PubMed ID: 23635385
[TBL] [Abstract][Full Text] [Related]
19. Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model.
Byrd MS; Pang B; Hong W; Waligora EA; Juneau RA; Armbruster CE; Weimer KE; Murrah K; Mann EE; Lu H; Sprinkle A; Parsek MR; Kock ND; Wozniak DJ; Swords WE
Infect Immun; 2011 Aug; 79(8):3087-95. PubMed ID: 21646454
[TBL] [Abstract][Full Text] [Related]
20. The innate immune protein calprotectin promotes Pseudomonas aeruginosa and Staphylococcus aureus interaction.
Wakeman CA; Moore JL; Noto MJ; Zhang Y; Singleton MD; Prentice BM; Gilston BA; Doster RS; Gaddy JA; Chazin WJ; Caprioli RM; Skaar EP
Nat Commun; 2016 Jun; 7():11951. PubMed ID: 27301800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
